Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05933655 · ClinicalTrials.gov registry record · NA

Re-thinking the Role of Peers And Training Patients [RePeAT]

A NA study of Cardiovascular Diseases, sponsored by University of Rochester.

Active
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05933655 is a NA study of Cardiovascular Diseases that is active but no longer recruiting, run by University of Rochester. The registered enrollment target is 60 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05933655, a NA study of Cardiovascular Diseases, is active but no longer recruiting, sponsored by University of Rochester.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study, Re-thinking the role of Peers And Training Patients \[RePeAT\], is designed to test the feasibility of training peer-coaches to prepare limited health literacy (LHL) patients to engage in shared-decision making (SDM) for cardiovascular disease (CVD) risk-reduction.

Conditions Studied

Interventions

  • BEHAVIORAL Peer Coach

Study Locations (1)

New York

  • University of Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-09-01
Est. Completion 2026-06
Phase NA

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT05933655

The ClinicalTrials.gov registry entry for NCT05933655 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Peer Coach is the first listed.

NCT05933655 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05933655 about?

NCT05933655 is a clinical study titled "Re-thinking the Role of Peers And Training Patients [RePeAT]". This study, Re-thinking the role of Peers And Training Patients \[RePeAT\], is designed to test the feasibility of training peer-coaches to prepare limited health literacy (LHL) patients to engage in shared-decision making (SDM) for cardiovascular disease (CVD) risk-reduction.

What is the current status of trial NCT05933655?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-09-01. Estimated completion is 2026-06.

What conditions does trial NCT05933655 study?

This clinical trial studies the following conditions: Cardiovascular Diseases.

What interventions are being tested in trial NCT05933655?

The interventions under investigation include: Peer Coach (BEHAVIORAL).

Who is sponsoring clinical trial NCT05933655?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05933655 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.